Share on StockTwits

UnitedHealth Group (NYSE:UNH) declared a quarterly dividend on Thursday, February 13th, Analyst Ratings Net reports. Shareholders of record on Friday, March 14th will be given a dividend of 0.28 per share on Tuesday, March 25th. This represents a $1.12 dividend on an annualized basis and a yield of 1.58%.

UNH has been the subject of a number of recent research reports. Analysts at TheStreet reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 22nd. One analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus target price of $78.72.

Shares of UnitedHealth Group (NYSE:UNH) opened at 70.75 on Thursday. UnitedHealth Group has a 52-week low of $52.51 and a 52-week high of $77.33. The stock has a 50-day moving average of $73.16 and a 200-day moving average of $72.34. The company has a market cap of $71.741 billion and a P/E ratio of 12.84.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Wednesday, January 15th. The company reported $1.41 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.40 by $0.01. The company had revenue of $31.10 billion for the quarter, compared to the consensus estimate of $31.06 billion. During the same quarter in the prior year, the company posted $1.20 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. Analysts expect that UnitedHealth Group will post $5.60 EPS for the current fiscal year.

UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.